Veracyte is a publicly traded molecular diagnostics company headquartered in San Francisco and founded in 2006. The company develops genomic and molecular tests for cancer diagnosis and classification, serving oncologists, surgeons, and patients. Veracyte is best known for the Afirma test for thyroid cancer diagnosis and has expanded into lung cancer and other malignancies. With approximately 800 employees, the company focuses on precision oncology, leveraging genomic analysis to provide accurate, actionable diagnostic information that improves patient outcomes and guides treatment decisions.
Veracyte operates as a science-driven organization centered on precision medicine and improving patient outcomes through accurate diagnostics. The company emphasizes rigorous scientific standards, continuous innovation in genomics, and collaborative development of reliable cancer tests. As a healthcare diagnostics company, it attracts talent motivated by direct patient impact while balancing commercial growth with clinical reliability and regulatory compliance.
2 open now, 2 first appeared in the last 30d.
| Title ↕ | Location ↕ | Posted ↓ |
|---|---|---|
| Research Associate I | South San Francisco, California, United States | 5d |
| Prosigna Sales Training Manager | Remote | 5d |